PRPO – Precipio Inc
Float Short %
0.33
Margin Of Safety %
-26
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
24.7
Target Price
19
Analyst Recom
1
Performance Q
12.51
Relative Volume
0.62
Beta
1.2
Ticker: PRPO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | PRPO | 23.76 | N/A | N/A | 0 |
| 2025-12-29 | PRPO | 23.89 | N/A | N/A | 0 |
| 2025-12-30 | PRPO | 23.41 | N/A | N/A | 0 |
| 2025-12-31 | PRPO | 22.99 | N/A | N/A | 0 |
| 2026-01-02 | PRPO | 23.38 | N/A | N/A | 0 |
| 2026-01-05 | PRPO | 23.74 | N/A | N/A | 0 |
| 2026-01-06 | PRPO | 22.98 | N/A | N/A | 0 |
| 2026-01-07 | PRPO | 23.52 | N/A | N/A | 0 |
| 2026-01-08 | PRPO | 23.71 | N/A | N/A | 0 |
| 2026-01-09 | PRPO | 24.77 | N/A | N/A | 0 |
| 2026-01-12 | PRPO | 26.0599 | N/A | N/A | 0 |
| 2026-01-13 | PRPO | 25.71 | N/A | N/A | 0 |
| 2026-01-14 | PRPO | 23.8 | N/A | N/A | 0 |
| 2026-01-15 | PRPO | 24 | N/A | N/A | 0 |
| 2026-01-16 | PRPO | 23.46 | N/A | N/A | 0 |
| 2026-01-20 | PRPO | 24.7 | N/A | N/A | 0 |
| 2026-01-21 | PRPO | 24.52 | N/A | N/A | 0 |
| 2026-01-22 | PRPO | 24.7 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | PRPO | 23.80 | - | - | - |
| 2025-12-29 | PRPO | 23.40 | - | - | - |
| 2025-12-30 | PRPO | 23.55 | - | - | - |
| 2025-12-31 | PRPO | 22.85 | - | - | - |
| 2026-01-02 | PRPO | 23.20 | - | - | - |
| 2026-01-05 | PRPO | 23.74 | - | - | - |
| 2026-01-06 | PRPO | 23.30 | - | - | - |
| 2026-01-07 | PRPO | 23.55 | - | - | - |
| 2026-01-08 | PRPO | 23.71 | - | - | - |
| 2026-01-09 | PRPO | 25.51 | - | - | - |
| 2026-01-12 | PRPO | 25.15 | - | - | - |
| 2026-01-13 | PRPO | 25.67 | - | - | - |
| 2026-01-14 | PRPO | 23.50 | - | - | - |
| 2026-01-15 | PRPO | 24.20 | - | - | - |
| 2026-01-16 | PRPO | 23.50 | - | - | - |
| 2026-01-20 | PRPO | 24.33 | - | - | - |
| 2026-01-21 | PRPO | 24.77 | - | - | - |
| 2026-01-22 | PRPO | 24.70 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | PRPO | -2.63 | 15.64 | 0.27 |
| 2025-12-29 | PRPO | -2.63 | 15.61 | 0.27 |
| 2025-12-30 | PRPO | -2.63 | 15.61 | 0.27 |
| 2025-12-31 | PRPO | -2.63 | 15.61 | 0.27 |
| 2026-01-02 | PRPO | -2.63 | 15.61 | 0.27 |
| 2026-01-05 | PRPO | -2.63 | 15.64 | 0.27 |
| 2026-01-06 | PRPO | -2.62 | 15.64 | 0.27 |
| 2026-01-07 | PRPO | -2.62 | 15.64 | 0.27 |
| 2026-01-08 | PRPO | -2.62 | 15.64 | 0.27 |
| 2026-01-09 | PRPO | -2.62 | 15.64 | 0.27 |
| 2026-01-12 | PRPO | -2.80 | 15.96 | 0.27 |
| 2026-01-13 | PRPO | -2.62 | 15.96 | 0.33 |
| 2026-01-14 | PRPO | -2.62 | 15.96 | 0.33 |
| 2026-01-15 | PRPO | -2.62 | 15.96 | 0.33 |
| 2026-01-16 | PRPO | -2.62 | 15.96 | 0.33 |
| 2026-01-20 | PRPO | -2.62 | 15.60 | 0.33 |
| 2026-01-21 | PRPO | -2.62 | 15.60 | 0.33 |
| 2026-01-22 | PRPO | -2.62 | 15.60 | 0.33 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
-2.62
Institutional Transactions
15.6
Beta
1.2
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
18.35
Quality Score
45
Growth Score
54
Sentiment Score
99
Actual DrawDown %
86.6
Max Drawdown 5-Year %
-95.8
Target Price
19
P/E
Forward P/E
PEG
P/S
1.87
P/B
3.1
P/Free Cash Flow
72.39
EPS
-0.83
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-5.5
Relative Volume
0.62
Return on Equity vs Sector %
-36.4
Return on Equity vs Industry %
-20
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading